Megalos Pharma Private Limited
About Megalos Pharma Private Limited
Data last updated:
Megalos Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 11 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC167908. Its GSTIN is 27AAKCM7689J1ZK (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Yogesh Gawade and Sujay Eknath Bombale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No.302 Payal Classic Sr No 16/24A/1 Solapur Road Hadapsar Pune, Maharashtra, India – 411028.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.7 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net profit of ₹17,050 (net margin 0.7%) and EBITDA of ₹24,617 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Megalos Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No.302 Payal Classic Sr No 16/24A/1 Solapur Road Hadapsar Pune, Maharashtra, India – 411028
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Megalos Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Megalos Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Megalos Pharma Private Limited, buy the company report.
Financials of Megalos Pharma Private Limited
FY 2025 filings availableMegalos Pharma Private Limited reported revenue of ₹23.7 Lakh (down 35% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 35% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24,617 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17,050 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Megalos Pharma Private Limited, buy the company report.
Board of directors of Megalos Pharma Private Limited
Megalos Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yogesh Gawade | Director | 11 Jan 2017 | 9 Years 9 Months | Current |
| Sujay Eknath Bombale | Director | 07 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Megalos Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Healthy Universe Private Limited | ₹23.81 Lakh (FY 2024) | -81.0% | Indore, Madhya Pradesh, India | |||
| Vitaduro Healthcare Private Limited | ₹23.79 Lakh (FY 2018) | 7.0% | Mumbai, Maharashtra, India | |||
| Zuku Life Sciences Private Limited | ₹23.76 Lakh (FY 2023) | -37.0% | Madurai, Tamil Nadu, India | |||
| Shayana Entertainments and Hospitality Private Limited | ₹23.75 Lakh (FY 2025) | 10.0% | Canacona, Goa, India | |||
| Grobin Pharmaceuticals Private Limited | ₹23.72 Lakh (FY 2019) | 271.0% | Patna, Bihar, India | |||
| Megalos Pharma Private Limitedthis company | ₹23.7 Lakh (FY 2024) | ₹17,050 | 0.7% | -35.0% | Pune, Maharashtra, India | |
| Uttamenergy Philanthropic Foundation | ₹23.7 Lakh (FY 2025) | -19.0% | Pune, Maharashtra, India | |||
| Ivrybliss Pharma (OPC) Private Limited | ₹23.68 Lakh (FY 2025) | 100.0% | Noida, Uttar Pradesh, India | |||
| Cuvet Eclipse Private Limited | ₹23.63 Lakh (FY 2019) | Bangalore, Karnataka, India | ||||
| Jots Pharmvet Private Limited | ₹23.63 Lakh (FY 2024) | -40.0% | New Delhi, Delhi, India | |||
| Shivik Pharmaceuticals Private Limited | ₹23.56 Lakh (FY 2024) | 720.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of Megalos Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Megalos Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Megalos Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Megalos Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCM7689J1ZK | Maharashtra | Active | 18 Sep 2017 |
To see the full GST registrations and return filing status of Megalos Pharma Private Limited, buy the company report.
Recent activity
Megalos Pharma Private Limited has 6 board changes on record since 2017: 2 appointments and 4 cessations. The latest: Sushen Shivaji Datkhile ceased to be Additional Director on 03 Jul 2025.
Frequently asked questions
Megalos Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 11 January 2017 (9+ years old) and is registered under CIN U74999PN2017PTC167908.
Megalos Pharma has 2 current directors:
- Yogesh Gawade - Director
- Sujay Eknath Bombale - Director
The latest financial statements of Megalos Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Megalos Pharma is 27AAKCM7689J1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Megalos Pharma is U74999PN2017PTC167908. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Megalos Pharma was incorporated on 11 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Megalos Pharma by revenue are Healthy Universe Private Limited, Vitaduro Healthcare Private Limited, Zuku Life Sciences Private Limited, Shayana Entertainments and Hospitality Private Limited, Grobin Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Sushen Shivaji Datkhile ceased to be Additional Director on 03 Jul 2025. Sujay Eknath Bombale ceased to be Additional Director on 30 Sep 2019. Santosh Vasant Deokate ceased to be Director on 19 Jul 2019. Megalos Pharma has 6 board changes on record in total.
The registered office of Megalos Pharma is at Flat No.302 Payal Classic Sr No 1624A1 Solapur Road Hadapsar Pune, Maharashtra, India – 411028.
Megalos Pharma operates in the business services industry, in the other services segment.
The compliance status of Megalos Pharma is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
